Press Releases

View Archive: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

12.18.03
FibroGen Initiates Open-Label, Phase 1 Clinical Trial of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis

11.12.03
FibroGen Announces Abstracts on Connective Tissue Growth Factor to be Presented at the 2003 Meeting of the American Society of Nephrology

8.11.03
FibroGen Appoints Claire J. Lockey, Vice President, Regulatory Affairs

7.21.03
FibroGen Announces Positive Results From First Clinical Trial of Recombinant Human Gelatin

7.9.03
FibroGen Receives National Cancer Institute Grant to Develop New Cancer Therapies Targeting Connective Tissue Growth Factor

1.22.03
FibroGen Appoints David Y. Liu, Ph.D., Vice President, Research